All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| RMED / Catheter Precision Inc.
|
|
|
|
|
|
|
|
| NVTR / Nuvectra Corporation
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DYNT / Dynatronics Corporation
|
|
|
|
|
|
|
|
| XENT / Intersect ENT Inc
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
| IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| ENZ / Enzo Biochem, Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| HBIO / Harvard Bioscience, Inc.
|
|
|
|
|
|
|
|
| LMAT / LeMaitre Vascular, Inc.
|
|
|
|
|
|
|
|
| TLGT / Teligent Inc
|
|
|
|
|
|
|
|
| GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| SHPG / Shire Plc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| KTWO / K2M Group Holdings, Inc.
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| STRM / Streamline Health Solutions, Inc.
|
|
|
|
|
|
|
|
| LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| IHI / iShares Trust - iShares U.S. Medical Devices ETF
|
|
|
|
|
|
|
|
| HSTM / HealthStream, Inc.
|
|
|
|
|
|
|
|
| IRIX / IRIDEX Corporation
|
|
|
|
|
|
|
|
| CSII / Cardiovascular Systems Inc.
|
|
|
|
|
|
|
|
| PSCH / Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Health Care ETF
|
|
|
|
|
|
|
|
| LHCG / LHC Group Inc
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
| HRC / Hill-Rom Holdings Inc
|
|
|
|
|
|
|
|
| TFX / Teleflex Incorporated
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| TECH / Bio-Techne Corporation
|
|
|
|
|
|
|
|
| SLP / Simulations Plus, Inc.
|
|
|
|
|
|
|
|
| ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
| MODN / Model N, Inc.
|
|
|
|
|
|
|
|
| KIDS / OrthoPediatrics Corp.
|
|
|
|
|
|
|
|
| SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RVTY / Revvity, Inc.
|
|
|
|
|
|
|
|
| HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| IBB / iShares Trust - iShares Biotechnology ETF
|
|
|
|
|
|
|
|
| NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| NVS / Novartis AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
| HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
| OMCL / Omnicell, Inc.
|
|
|
|
|
|
|
|
